Stay updated on Cabozantinib in RAI-Refractory DTC Clinical Trial
Sign up to get notified when there's something new on the Cabozantinib in RAI-Refractory DTC Clinical Trial page.

Latest updates to the Cabozantinib in RAI-Refractory DTC Clinical Trial page
- Check2 days agoNo Change Detected
- Check9 days agoChange DetectedThe revision label at the bottom updates from v3.6.4 to v3.6.5, indicating a new page release. This change updates the page metadata without altering the study details or visible content.SummaryDifference0.1%

- Check17 days agoNo Change Detected
- Check24 days agoChange DetectedFooter revision updated from v3.6.3 to v3.6.4, reflecting a minor site update. No study content or functionality appears to be affected.SummaryDifference0.1%

- Check45 days agoChange DetectedThe page now displays Revision: v3.6.3, replacing the previous Revision: v3.6.2. This indicates a minor update to the page's underlying template or content.SummaryDifference0.1%

- Check53 days agoChange DetectedThe page footer now displays Revision: v3.6.2, indicating a minor page revision. This update does not affect the main content or functionality of the study record.SummaryDifference0.1%

- Check67 days agoChange DetectedThe page now includes new metadata fields Last verified and Last known status was:, and adds user help links such as How to Read a Study Record, Common Questions, and How to Join a Study. The Intervention/Treatment label is reformatted from Interven tion / Treatment, and the footer shows Revision: v3.6.0.SummaryDifference2%

- Check74 days agoChange DetectedThe page’s revision label updated from v3.5.4 to v3.5.5, indicating a small, behind-the-scenes update to the page. No modifications to trial details or visible content are indicated by this change.SummaryDifference0.1%

Stay in the know with updates to Cabozantinib in RAI-Refractory DTC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Cabozantinib in RAI-Refractory DTC Clinical Trial page.